--- title: "Embecta Corp. (EMBC.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/EMBC.US.md" symbol: "EMBC.US" name: "Embecta Corp." industry: "医疗用品" --- # Embecta Corp. (EMBC.US) | Item | Detail | |------|--------| | Industry | 医疗用品 | | Location | 美股市场 | | Website | [www.embecta.com](https://www.embecta.com) | ## Company Profile Embecta Corp.是一家医疗设备公司,提供解决方案以改善美国及国际上糖尿病患者的健康和福祉。该公司的产品包括笔针、注射器和安全注射设备,以及帮助患者管理糖尿病的数字应用程序。它主要将产品销售给批发商和分销商。该公司之前被称为 Berra Newco, Inc ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-16T04:30:14.000Z **Overall: C (0.55)** **Industry**: Health Care Supplies | Metric | Value | |--------|-------| | Industry Ranking | 19 / 43 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -2.53% | | | Net Profit YoY | 139.69% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | -0.98 | | | Dividend Ratio | 5.90% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 602.27M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 1.08B | | **Multi Score**: C #### Profit Score: C | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -20.19% | E | | Profit Margin | 12.92% | B | | Gross Margin | 61.91% | A | #### Growth Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -2.53% | D | | Net Profit YoY | 139.69% | A | | Total Assets YoY | -7.46% | D | | Net Assets YoY | 20.25% | A | #### Cash Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 773.98% | B | | OCF YoY | -2.53% | D | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.98 | A | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 157.64% | E | ```chart-data:radar { "title": "Longbridge Financial Score - Embecta Corp.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "C", "indicators": [ { "name": "ROE", "value": "-20.19%", "rating": "E" }, { "name": "Profit Margin", "value": "12.92%", "rating": "B" }, { "name": "Gross Margin", "value": "61.91%", "rating": "A" } ] }, { "name": "Growth", "grade": "C", "indicators": [ { "name": "Revenue YoY", "value": "-2.53%", "rating": "D" }, { "name": "Net Profit YoY", "value": "139.69%", "rating": "A" }, { "name": "Total Assets YoY", "value": "-7.46%", "rating": "D" }, { "name": "Net Assets YoY", "value": "20.25%", "rating": "A" } ] }, { "name": "Cash", "grade": "C", "indicators": [ { "name": "Cash Flow Margin", "value": "773.98%", "rating": "B" }, { "name": "OCF YoY", "value": "-2.53%", "rating": "D" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "0.98", "rating": "A" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "157.64%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | 依视路(ADR) (US.ESLOY) | B | B | C | B | B | B | | 02 | HOYA Corporation (US.HOCPY) | A | B | B | A | C | B | | 03 | 爱齐科技 (US.ALGN) | B | C | B | B | C | B | | 04 | Merit医疗系统 (US.MMSI) | B | B | B | C | B | B | | 05 | UFP 科技 (US.UFPT) | B | B | A | B | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 4.32 | 3/44 | 12.42 | 10.54 | 7.82 | | PB | -0.98 | 41/44 | - | - | - | | PS (TTM) | 0.56 | 6/44 | 0.74 | 0.66 | 0.57 | | Dividend Yield | 5.90% | 1/44 | 5.69% | 4.84% | 4.28% | ## Institutional View ### Analyst Rating Distribution > As of 2026-02-06T05:00:00.000Z Total Analysts: **4** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 1 | 25% | | Overweight | 0 | 0% | | Hold | 2 | 50% | | Underweight | 1 | 25% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 10.17 | | Highest Target | 25.00 | | Lowest Target | 11.00 | ## References - [Company Overview](https://longbridge.com/en/quote/EMBC.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/EMBC.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/EMBC.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.